22q11 Deletion Syndrome
Information
- Disease name
- 22q11 Deletion Syndrome
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05290493 | Completed | Phase 2 | NB-001 in Children and Adolescents With 22q11 Deletion Syndrome | February 10, 2022 | June 9, 2023 |
| NCT02381457 | Completed | SNP-based Microdeletion and Aneuploidy RegisTry (SMART) | April 2015 | June 2020 | |
| NCT06081348 | Not yet recruiting | Phase 2 | Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders | October 2023 | April 2024 |
| NCT04463316 | Recruiting | GROWing Up With Rare GENEtic Syndromes | October 1, 2018 | January 1, 2030 | |
| NCT05664412 | Recruiting | N/A | Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome | October 20, 2023 | January 2025 |
| NCT05849441 | Recruiting | N/A | Mindfulness Program for Adolescents With 22q11DS | December 18, 2023 | September 2024 |
| NCT02070211 | Unknown status | Phase 2/Phase 3 | Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome. | June 2014 | June 2016 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D058165